Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The GLP-1 trade has matured from a single-stock story into a tiered opportunity set
Semaglutide 2.4mg (GLP-1 Agonist): Proven GLP-1 effects (appetite suppression, gastric emptying) Already FDA-approved as Wegovy Established safety profile Cagrilintide 2.4mg (Amylin Analog): Mimics amylin, a hormone co-secreted with insulin Slows gastric emptying through different pathway than GLP-1 Reduces appetite through hindbrain (not hypothalamus) Improves postprandial glucose The Advantage: Leverages proven semaglutide efficacy and safety, adds complementary amylin effects
Gastritis reduces the production of hydrochloric acid which leads to the growth of intestinal bacteria
Comparing them across categories like peptides for weight loss and pharmaceutical GLP-1 agonists helps frame the decision more clearly
It also counteracts the increased appetite that follows weight loss [112, 113]
Green Tea: Catechins improve fat metabolism and reduce liver inflammation
